We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+20.33%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$600M
AUM Growth
+$79.5M
(+15%)
Cap. Flow
+$21.8M
Cap. Flow
% of AUM
3.64%
Top 10 Holdings %
Top 10 Hldgs %
21.67%
Holding
133
New
15
Increased
59
Reduced
31
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merit Medical Systems
MMSI
|
+$6.18M |
| 2 |
Privia Health
PRVA
|
+$5.98M |
| 3 |
CONMED
CNMD
|
+$5.55M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
+$5.01M |
| 5 |
MoonLake Immunotherapeutics
MLTX
|
+$4.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$12.1M |
| 2 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
+$11.6M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
+$6.67M |
| 4 |
BLU
BELLUS Health Inc.
BLU
|
+$5.53M |
| 5 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
+$5.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.97% |
| 2 | Industrials | 3.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Illumina
ILMN
$31B
| $1.02M | 0.17% |
5,584
+937
| +20% | +$190K |
|
|
HZNP
102
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $812K | 0.14% |
7,899
+1,999
| +34% | +$211K |
|
103
Sanofi
SNY
$103B
| $587K | 0.1% |
10,896
+1,996
| +22% | +$107K |
|
104
Legend Biotech
LEGN
$3.69B
| $552K | 0.09% |
8,000
-2,000
| -20% | -$131K |
|
105
Incyte
INCY
$24.9B
| $509K | 0.08% |
8,178
+1,498
| +22% | +$100K |
|
106
Dr. Reddy's Laboratories
RDY
$9.85B
| $505K | 0.08% |
40,020
| – | – |
|
107
United Therapeutics
UTHR
$26.2B
| $496K | 0.08% |
2,247
+432
| +24% | +$95.7K |
|
108
Royalty Pharma
RPRX
$26.2B
| $472K | 0.08% |
15,362
+2,922
| +23% | +$99K |
|
109
Jazz Pharmaceuticals
JAZZ
$16.2B
| $413K | 0.07% |
3,334
+1,164
| +54% | +$157K |
|
110
argenx
ARGX
$54.6B
| $411K | 0.07% |
1,054
+204
| +24% | +$80.2K |
|
111
BioNTech
BNTX
$23.5B
| $359K | 0.06% |
3,329
+629
| +23% | +$70.7K |
|
112
Neurocrine Biosciences
NBIX
$18.7B
| $326K | 0.05% |
3,460
+660
| +24% | +$64.5K |
|
113
Tempest Therapeutics
TPST
$13.8M
| $279K | 0.05% |
+16,876
| New | +$425K |
|
114
Medpace
MEDP
$16.1B
| $270K | 0.05% |
1,126
+156
| +16% | +$32.4K |
|
|
FUSN
115
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $268K | 0.04% |
57,297
| – | – |
|
116
Roivant Sciences
ROIV
$24.9B
| $256K | 0.04% |
25,427
+4,427
| +21% | +$39.6K |
|
117
Ascendis Pharma A/S
ASND
$16.5B
| $250K | 0.04% |
2,796
+1,106
| +65% | +$96.3K |
|
118
Zai Lab
ZLAB
$2.06B
| $222K | 0.04% |
8,000
-3,922
| -33% | -$128K |
|
119
Arvinas
ARVN
$536M
| $153K | 0.03% |
6,175
-198,939
| -97% | -$5.12M |
|
120
Arcutis Biotherapeutics
ARQT
$3.5B
| $136K | 0.02% |
14,287
-302,865
| -95% | -$3.36M |
|
121
Summit Therapeutics
SMMT
$10.7B
| $126K | 0.02% |
50,000
+30,000
| +150% | +$54.8K |
|
122
Alignment Healthcare
ALHC
$3.85B
| – | – |
-471,000
| Closed | -$3M |
|
123
Altimmune
ALT
$580M
| – | – |
-479,100
| Closed | -$2.02M |
|
124
4D Molecular Therapeutics
FDMT
$526M
| – | – |
-80,029
| Closed | -$1.38M |
|
|
MRSN
125
DELISTED
Mersana Therapeutics
MRSN
| – | – |
-13,723
| Closed | -$1.41M |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, Sectoral Asset Management held 133 positions worth $600M, up 15% from $520M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Sectoral Asset Management deployed $21.8M of net new capital in Q2 2023, opening 15 new positions and adding to 59 existing holdings. Its largest new stake was Merit Medical Systems: 76,000 shares worth $6.36M.
By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier, followed by Industrials.
On the sell side, the largest reduction was Shockwave Medical, Inc. Common Stock, an estimated $12.1M trimmed.
- Sectoral Asset Management's largest Q2 2023 buy was Merit Medical Systems: 76,000 shares worth $6.36M.
- Sectoral Asset Management added most to Privia Health in Q2 2023, an estimated $5.98M increase.
- Sectoral Asset Management's biggest Q2 2023 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $12.1M.
- Sectoral Asset Management fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $11.6M.
- Sectoral Asset Management's ten largest holdings make up 22% of its $600M portfolio in Q2 2023.
- Sectoral Asset Management opened 15 new positions and closed 12 in Q2 2023.
- Sectoral Asset Management's portfolio value rose 15% quarter-over-quarter to $600M.
Based on Sectoral Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.